| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alzamend Neuro, Inc. (ALZN) has 3 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. ALZN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 25 | $26.00 | - | |
| Dir | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2022 | Ault Milton C III | 10% Owner | Buy | 2,000 | $0.94 | $1,881.40 | - | +6.6% | -25.5% | |
| Jun 2, 2022 | Ault Milton C III | 10% Owner | Buy | 8,000 | $0.96 | $7,679.20 | - | -5.2% | -23.5% | |
| May 27, 2022 | Ault Milton C III | 10% Owner | Buy | 22,000 | $0.94 | $20,626.80 | +0.1% | -0.2% | -32.1% | |
| May 24, 2022 | Ault Milton C III | 10% Owner | Buy | 16,100 | $0.89 | $14,306.46 | +0.2% | +9.8% | -33.3% | |
| May 17, 2022 | Ault Milton C III | 10% Owner | Buy | 23,900 | $0.98 | $23,343.13 | +0.2% | +5.1% | -47.0% | |
| May 12, 2022 | Ault Milton C III | 10% Owner | Buy | 125,000 | $0.97 | $121,297.50 | +0.6% | +16.1% | -43.0% | |
| May 5, 2022 | Ault Milton C III | 10% Owner | Buy | 100,000 | $1.07 | $106,850.00 | +44.4% | -13.7% | -51.5% | |
| Apr 26, 2022 | Ault Milton C III | 10% Owner | Buy | 2,666,667 | $1.50 | $4,000,000.50 | +38.1% | -2.3% | -42.1% | |
| Apr 22, 2022 | Ault Milton C III | 10% Owner | Buy | 75,000 | $0.94 | $70,335.00 | +50.0% | +5.2% | -33.6% | |
| Apr 11, 2022 | Ault Milton C III | 10% Owner | Buy | 50,000 | $1.13 | $56,325.00 | +50.0% | -9.5% | -50.9% |